Table 2.
Relative quantification of gene expression normalized by the BMG gene in patients with MM.
| Untreated Group without PN (n=59) |
Treated Group with PN (n=34) | Treated Group without PN (n=27) |
p-Value * Treated Group with PN vs. Untreated Group without PN |
p-Value * Treated Group without PN vs. Untreated Group without PN |
p-Value * Treated Group with PN vs. Treated Group without PN |
|
|---|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ±SD | ||||
| CCL2 | 14.86 ± 15.37 | 19.73 ± 36.06 | 13.09 ± 30.19 | 0.5549 | 0.1727 | 0.5516 |
| IFN-γ | 26.04 ± 49.66 | 61.57 ± 137.09 | 14.94 ± 24.37 | 0.1003 | 0.2621 | 0.0085 |
| IL-1β | 58.60 ± 56.64 | 88.72 ± 109.22 | 48.06 ± 54.62 | 0.1962 | 0.4049 | 0.0516 |
| CFP | 1.38 ± 4.03 | 4.93 ± 15.53 | 1.44 ± 3.68 | 0.0098 | 0.3331 | 0.1118 |
| CFD | 16.97 ± 35.33 | 36.28 ± 61.80 | 16.79 ± 21.30 | 0.0119 | 0.6924 | 0.0571 |
* Mann–Whitney test. In bold, p-values < 0.05.